ReviewInternational journal of cardiology. Heart & vasculature2026
Superimposed Takotsubo syndrome and acute myocardial infarction: a systematic review and pooled analysis of published cases.
Review in International journal of cardiology. Heart & vasculature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takotsubo syndrome (TTS) has traditionally been regarded as a diagnosis of exclusion requiring the absence of obstructive coronary artery disease. However, increasing evidence suggests that acute myocardial infarction (AMI) and TTS may coexist as a combined overlap phenotype. We refer to this entity as STAMI (Superimposed Takotsubo and Acute Myocardial Infarction). This review summarizes currently available evidence regarding the clinical characteristics, imaging findings, mechanisms, and outcomes of this underrecognized syndrome. A systematic review of published case reports and case series identified 48 patients with simultaneous AMI and TTS reported between 2000 and 2025. The mean age was 67 years and 69% were women. STEMI was present in 57% and NSTEMI in 41% of cases. Although atherosclerotic plaque rupture was the predominant infarct mechanism, vasospasm and spontaneous coronary artery dissection accounted for more than 20% of presentations. A consistent finding across reports was an anatomical-functional mismatch in which wall-motion abnormalities extended beyond the culprit coronary territory, most commonly manifesting as apical ballooning. Marked QTc prolongation and disproportionately elevated natriuretic peptide levels were recurrent features. Initial left ventricular dysfunction was often severe but demonstrated substantial recovery during follow-up, supporting the presence of reversible stress-induced myocardial stunning in addition to ischemic injury. Cardiogenic shock occurred in approximately 10% of patients, while in-hospital mortality was 6.3%. Recognition of STAMI is clinically important because ventricular dysfunction frequently exceeds the expected infarct territory and may influence diagnostic interpretation, risk stratification, and therapeutic management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.